|
|
|
|
|
|
|
|
Editorial - open access:
Global reach: Promoting ethical best practices and the quality and integrity of medical publications worldwide - Current Medical Research and Opinion - Volume 32, Issue sup1
According to most
measures of scientific output, the volume of citable scientific
literature worldwide is increasing astronomically each year. It has been
estimated that a new life science paper appears in print or online
every minute or less. As most of us know, the amount of data generated
from just a single clinical trial can be so extensive that much of it,
when published, has to reside in online supplementary appendices, which
can be many times longer than the primary publication, and key
information may be lost in the vast expanse of supplementary figures,
tables, and other material.
This raises a
fundamental issue – how can we present this explosion of data in a way
that people can understand it? At least one answer is through the
application of interpretation. Technology allows us to make vast
quantities of data widely available, but without context it is almost
impossible for the end user to process. We need individuals who have the
skills to change data from a (sometimes enormous) collection of facts
to an understandable narrative and, conversely, we need to ensure that
any narrative is more than just professional opinion or conjecture, but
is backed up by evidence. In fact, scientific publications have been
described as “stories that persuade with data.”1
This linking of data and meaning in the scientific literature, and
ensuring the information reaches the appropriate audience in a timely
manner, is where the medical publication professional can add tremendous
value. Sharing scientific knowledge, primarily through publication in
some form (whether digital or otherwise) is fundamental to the
scientific process, and researchers, who are both producers and
consumers of data, can benefit from a partnership with highly skilled
individuals who understand not just the scientific process, but also the
legal, regulatory, and ethical issues surrounding data dissemination.
A Global Outlook
If
we look at the volume of medical or pharmacological information
produced, the most prolific generator of citable publications for the
last ten or more years has been the United States, with China, India,
Japan, the United Kingdom, and other European countries populating the
top ten. However, while output from the United States has remained
relatively steady, output from China is increasing substantially, so
much so that it is on course to overtake the United States as the
leading producer of scientific data. Thus, it is appropriate and timely
that ISMPP held its first Asia-Pacific Meetings in Beijing, China and
Tokyo, Japan in August and September last year. These inaugural meetings
were the culmination of considerable efforts by the Asia-Pacific
Advisory Committee and Asia-Pacific Education Task Force, and highlight
ISMPP’s strategic commitment to expanding beyond the US and Europe to
promote ethical and transparent scientific exchange. These very
successful events provided ISMPP with an opportunity to promote
effective and ethical publication practices, and provided the attendees
with the means to help influence the future of medical publication
ethics in these regions. One of ISMPP’s goals over the next few years is
to build on these budding relationships, explore more ways of
collaborating with these prolific producers of scientific data, and
provide resources to promote integrity and ethical best practices in
medical publications.
ISMPP’s activities in
China and Japan coincided with the publication in August of the ‘Good
Publication Practice for Communicating Company-Sponsored Medical
Research: GPP3’, guidelines which were initiated and sponsored by ISMPP.2
These updated guidelines expand on earlier versions, include new
content on topics such as data sharing and authorship, and provide ten
key “Principles of Good Publication Practice for Company-Sponsored
Medical Research.” ISMPP is also supporting the translation of GPP3 into
Chinese and Japanese, further evidence of our commitment to a more
global presence.
Where next?
ISMPP
is now in its 11th year. The previous 10 years have seen significant
achievements for the Society, advancing the medical publication
profession through driving transparency, improving standards and best
practices, providing education and advocacy, and further developing our
credibility through the ISMPP Certified Medical Publication
Professional™ (CMPP) credential program. However, we still have much to
do, as the channels and processes for global scientific discourse change
and as the production of medical and scientific data increases. Growing
concerns about fraud in the scientific literature reinforce the need
for ISMPP to leverage its increasingly global presence to support
ethical and transparent medical publication practices. In its second
decade, ISMPP must be at the forefront of these developments and ensure
that our members worldwide are well equipped to improve the quality,
completeness, transparency, and integrity of medical publications.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.